The American Migraine Foundation’s Dodick Lighthouse Research Award funds innovative, clinically relevant research to advance migraine and headache care with a focus on rapid translation to patient outcomes.
Funder: American Migraine Foundation
Due Dates (Anticipated): April 2027 (Letter of Intent) | July 2027 (Full application)
Funding Amounts: Up to $150,000 total over 2 years; typically 3 awards per cycle.
Summary: Supports innovative, patient-centered research projects in headache and migraine with a focus on clinical relevance and rapid translation to care.
Key Information: This is a forecasted opportunity; all dates are projected and subject to change.
This award, offered by the American Migraine Foundation (AMF) in collaboration with the American Headache Society, is designed to fund high-impact, patient-centered research in headache and migraine. The focus is on studies with clear clinical relevance and the potential for rapid translation to improved patient care. Projects should address critical gaps in migraine diagnosis, treatment optimization, mechanistic understanding, care delivery, and health equity, aligning with NIH and international expert panel research priorities. The award encourages work that can quickly inform clinical decision-making, care models, or therapeutic strategies, with an emphasis on actionable outcomes that improve patient care and reduce the burden of migraine and headache disorders.